Loading insider details...
Beta
Latest Form 4 (Jun 24, 2024): Grant/Award of 50,000 VIRX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 24, 2024 | Viracta Therapeutics, Inc. (VIRX) | Grant/Award | 50,000 | n/a |
| Jun 9, 2023 | Viracta Therapeutics, Inc. (VIRX) | Grant/Award | 40,000 | n/a |
| Jun 10, 2022 | Viracta Therapeutics, Inc. (VIRX) | Grant/Award | 40,000 | n/a |
| Mar 30, 2021 | Viracta Therapeutics, Inc. (VIRX) | Grant/Award | 80,000 | n/a |
| Jan 15, 2021 | Forte Biosciences, Inc. (FBRX) | Exercise/Conversion | 500 | $4.8K |
| Jun 15, 2020 | Tocagen Inc (TOCA) | Grant/Award | 1,858 | n/a |